Screen early. Screen annually.
1st
Colon cancer is the leading cause of cancer death in men under the age of 50 and the second leading cause in women.1
90%
9 in 10 colon cancer deaths are preventable when detected early.2 This is why health organizations like the US Preventive Services Task Force and the American College of Gastroenterology recommend that people over the age of 45 who are at average risk* for colon cancer should be screened annually with fecal immunochemical testing (FIT).3–5
OC-Auto FIT: The #1 automated noninvasive CRC screening tool in the world6
LEARN about the benefits of screening with OC-Auto FIT
USE your OC-Auto FIT at-home screening kit
*Professional guidelines recommend regular colon cancer screening for all average-risk adults between 45-75 years of age.3-5 For screening purposes, you are at average risk of colorectal cancer if you do not have a personal history of colorectal cancer or certain types of polyps; a family history of colorectal cancer; a confirmed or suspected hereditary colorectal cancer syndrome, such as familial adenomatous polyposis (FAP) or Lynch syndrome (hereditary nonpolyposis colon cancer or HNPCC); a personal history of inflammatory bowel disease (ulcerative colitis or Crohn’s disease); or a personal history of abdominal or pelvic radiation for a previous cancer. Talk to your healthcare provider if you are not sure if you are at average or increased risk of colorectal cancer.7
OC-Auto Sensor io iFOB Test is designed to be used together as an immunoassay test system. The test system is intended for the qualitative detection of fecal occult blood in feces by professional laboratories. The automated test is used for the measurement of fecal occult blood and is useful as an aid to detect blood in stool when lower gastrointestinal bleeding may be suspected.
References:
- Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12-49. doi:10.3322/caac.21820
- Tepus M, Yau TO. Non-invasive colorectal cancer screening: an overview. Gastrointest Tumors. 2020;7(3):62-73.doi:10.1159/000507701
- US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238
- Shaukat A, Kahi CJ, Burke CA, et al. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021;116(3):458-479. doi:10.14309/ajg.000000000000122
- Rex DK, Boland CR, Dominitz JA, et al. Colorectal Cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016-1030. doi:10.1038/ajg.2017.174
- Data on file with Polymedco, Inc.
- Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guidelines update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281. doi:10.3322/caac.21457
